NCT03368690 is a NA clinical trial of Oligopin® in ADHD, sponsored by Taipei Medical University.

Who is sponsoring NCT03368690?

NCT03368690 is sponsored by Taipei Medical University.

What drugs are being tested in NCT03368690?

Interventions in NCT03368690: Oligopin®, Placebo.

Is NCT03368690 still recruiting?

NCT03368690 is currently completed. Last updated 18 September 2019.

Last reviewed 2019-09-18 · How we verify

NCT03368690

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder

Completed NA Last updated 18 September 2019

What this trial tests

NA trial testing Oligopin® in ADHD in 32 participants. Completed in 23 August 2019.

Timeline

28 October 2017

Primary endpoint
21 June 2019

23 August 2019

Quick facts

Lead sponsor	Taipei Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	prevention
Enrollment	32
Start date	28 October 2017
Primary completion	21 June 2019
Estimated completion	23 August 2019
Sites	2 locations across Taiwan

Drugs / interventions tested

Oligopin®
Placebo

Conditions studied

ADHD — all drugs for ADHD →

Sponsor

Taipei Medical University

Who can join

Adults 7 to 64, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators will investigate the effects of polyphenolic extract from pine bark on the inattention and hyperactivity in patients with attention deficit hyperactivity disorder (ADHD) based on antioxidative status.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pine bark (Pinus spp.) extract for treating chronic disorders.
Robertson NU, Schoonees A, Brand A, Visser J. · · 2020 · cited 22× · PMID 32990945 · DOI 10.1002/14651858.cd008294.pub5

Verify or expand the search:

Other trials of Oligopin®

Trials testing the same drug.

NCT04488653 — A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome · NA · unknown

Other recruiting trials for ADHD

Currently open trials in the same condition.

NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
NCT07262853 — Dual Executive Function Training Package · NA · recruiting
NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting

Other Taipei Medical University trials

Trials by the same sponsor.

NCT07496658 — Nutritional Status, Nutritional Knowledge and Mental Health Among Indonesian Migrant Workers in Taiwan · not yet recruiting
NCT06930313 — Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) · NA · not yet recruiting
NCT07349446 — Effects of Circadian-Based Acupressure on Sleep Quality in Nursing Home Residents · NA · not yet recruiting
NCT07259369 — The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients · NA · not yet recruiting
NCT07275372 — Using Virtual Humans to Teach Cognitive Function Assessment to Nursing Students · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03368690 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University
Last refreshed: 18 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03368690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing